Management of neuroborreliosis in European adult patients

Acta Neurologica Scandinavica

Volumn 117, Issue SUPPL. 188, 2008, Pages 22-28

  Ljostad U ^a   Henriksen, T H ^a  

^a Sørlandet Sykehus HF Kristiansand ^*  (Norway)

Author keywords

Antibodies; Borrelia burgdorferi; Diagnosis; Lyme neuroborreliosis; Sensitivity; Specificity

Indexed keywords

CEFTRIAXONE; CHLOROQUINE; DOXYCYCLINE; IMIDAZOLE DERIVATIVE; MACROLIDE; PENICILLIN G; ANTIINFECTIVE AGENT;

ANTIGENIC VARIATION; BACTERIUM DETECTION; BORRELIA BURGDORFERI; BORRELIA GARINII; BORRELIA INFECTION; CLINICAL FEATURE; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; LABORATORY TEST; LYME DISEASE; LYMPHOCYTE TRANSFORMATION TEST; NEUROBORRELIOSIS; NONHUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; ADULT; DRUG ADMINISTRATION; EUROPE;

ADULT; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; EUROPE; HUMANS; LYME NEUROBORRELIOSIS; PROGNOSIS;

EID: 42649093171     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01027.x     Document Type: Review

References (43)

1. Cadavid D, O'neill T, Schaefer H, Pachner AR. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease. Lab Invest 2000 80: 1043 54.
2. Rupprecht TA, Koedel U, Fingerle V, Pfister HW. The pathogenesis of Lyme neuroborreliosis - from infection to inflammation. Mol Med 2008 14: 205 12.
3. Strle F, Ruzic-Sabljic E, Cimperman J, Lotric-Furlan S, Maraspin V. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 2006 43: 704 10.
4. Feder HM Jr., Johnson BJ, O'connell S, Shapiro ED, Steere AC, Wormser GP. A critical appraisal of "chronic Lyme disease". N Engl J Med 2007 357: 1422 30.
5. Ljostad U, Okstad S, Topstad T, Mygland A, Monstad P. Acute peripheral facial palsy in adults. J Neurol 2005 252: 672 6.
6. Mygland A, Skarpaas T, Ljostad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol 2006 13: 1213 5.
7. Oschmann P, Dorndorf W, Hornig C, Schafer C, Wellensiek HJ, Pflughaupt KW. Stages and syndromes of neuroborreliosis. J Neurol 1998 245: 262 72.
8. Halperin JJ, Logigian EL, Finkel MF, Pearl RA. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996 46: 619 27.
9. Lebech AM, Hansen K, Brandrup F, Clemmensen O, Halkier-Sorensen L. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn 2000 5: 139 50.
10. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev 2005 18: 484 509.
11. Karlsson M, Hovind-Hougen K, Svenungsson B, Stiernstedt G. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 1990 28: 473 9.
12. Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 1997 10: 185 201.
13. Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol 1991 30: 197 205.
14. Ljostad U, Skarpaas T, Mygland A. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol 2007 14: 873 6.
15. Hammers-Berggren S, Hansen K, Lebech AM, Karlsson M. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology 1993 43: 169 75.
16. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol 1999 37: 3990 6.
17. Skarpaas T, Ljostad U, Sobye M, Mygland A. Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborreliosis. Eur J Clin Microbiol Infect Dis 2007 14: 873 6.
18. Brunner M, Sigal LH. Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi. J Clin Microbiol 2001 39: 3213 21.
19. Marques AR, Hornung RL, Dally L, Philipp MT. Detection of immune complexes is not independent of detection of antibodies in Lyme disease patients and does not confirm active infection with Borrelia burgdorferi. Clin Diagn Lab Immunol 2005 12: 1036 40.
20. Valentine-Thon E, Ilsemann K, Sandkamp M. A novel lymphocyte transformation test (LTT-MELISA) for Lyme borreliosis. Diagn Microbiol Infect Dis 2007 57: 27 34.
21. Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 2005 65: 448 50.
22. Halperin JJ. Nervous system Lyme disease. Vector Borne Zoonotic Dis 2002 2: 241 7.
23. Stanek G, O'connell S, Cimmino M et al. European Union concerted action on risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996 108: 741 7.
24. Pfister HW, Rupprecht TA. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients. Int J Med Microbiol 2006 296: 11 6.
25. Kruger H, Kohlhepp W, Konig S. Follow-up of antibiotically treated and untreated neuroborreliosis. Acta Neurol Scand 1990 82: 59 67.
26. Halperin JJ, Shapiro ED, Logigian E et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007 69: 91 102.
27. Borg R, Dotevall L, Hagberg L et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis 2005 37: 449 54.
28. Kohlhepp W, Oschmann P, Mertens HG. Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G. J Neurol 1989 236: 464 9.
29. Dotevall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis 1999 28: 569 74.
30. Halperin JJ. Diagnosis and treatment of the neuromuscular manifestations of lyme disease. Curr Treat Options Neurol 2007 9: 93 100.
31. Oksi J, Nikoskelainen J, Hiekkanen H et al. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 2007 26: 571 81.
32. Dattwyler RJ, Wormser GP, Rush TJ et al. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr 2005 117: 393 7.
33. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-y follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002 34: 421 5.
34. Vrethem M, Hellblom L, Widlund M et al. Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study. Acta Neurol Scand 2002 106: 205 8.
35. Ljostad U, Mygland A, Skarpaas T. Neuroborreliosis in Vest-Agder. Tidsskr Nor Laegeforen 2003 123: 610 3.
36. Klempner MS, Hu LT, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001 345: 85 92.
37. Krupp LB, Hyman LG, Grimson R et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003 60: 1923 30.
38. Brorson O, Brorson SH. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection 1998 26: 144 50.
39. Murgia R, Cinco M. Induction of cystic forms by different stress conditions in Borrelia burgdorferi. APMIS 2004 112: 57 62.
40. Brorson O, Brorson SH. Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes. Infection 1997 25: 240 6.
41. Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole. APMIS 1999 107: 566 76.
42. Fitzgerald D, Haas D. Mycobacterium Tuberculosis. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. Philadelphia, PA: Elsevier Churchill Livingstone, 2005 2852 86.
43. Keller TL, Halperin JJ, Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology 1992 42: 32 42.